Alexza Pharma (ALXA) Tops Q4 EPS by 33c
Tweet
Share
E-mailGet Alerts ALXA Hot Sheet
Price: $0.92 --0%
Financial Fact:
Net loss attributable to Alexza common stockholders: -3.02M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Net loss attributable to Alexza common stockholders: -3.02M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Alexza Pharma (NASDAQ: ALXA) reported Q4 EPS of ($0.35), $0.33 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $1.45 billion, versus $1.3 million reported last year.
For earnings history and earnings-related data on Alexza Pharma (ALXA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deere shares climb as fiscal Q3 earnings and revenue top estimates
- Dingdong (DDL) Reports Q2 EPS of RMB0.90
- NetEase (NTES) Misses Q2 EPS by 352c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
